Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE5415.40115.4 (+2.18 %)

PREV CLOSE ( ) 5300.00

OPEN PRICE ( ) 5381.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1499

TODAY'S LOW / HIGH ( )5349.25 5514.70

52 WK LOW / HIGH ( )3128.5 7208

NSE5425.8093.55 (+1.75 %)

PREV CLOSE( ) 5332.25

OPEN PRICE ( ) 5377.00

BID PRICE (QTY) 5425.80 (55)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 11479

TODAY'S LOW / HIGH( ) 5335.35 5520.00

52 WK LOW / HIGH ( )3125 7220.95

Quarters

Select year

( in Million)

Particulars

Dec 2023

Sep 2023

Jun 2023

Mar 2023

Audited / UnAudited

UnAudited

Net Sales

3057.89

3110.72

2954.67

2847.03

Total Expenditure

2907.33

2583.12

2282.22

2248.55

PBIDT (Excl OI)

150.56

527.6

672.45

598.48

Other Income

96.6

83.73

81.04

79.97

Operating Profit

247.16

611.32

753.49

678.46

Interest

6.13

1.54

0.88

Exceptional Items

164.26

-402.29

PBDT

241.03

770.58

751.95

275.29

Depreciation

37.05

36.74

37.98

42.49

Profit Before Tax

203.98

733.84

713.97

232.8

Tax

45.98

210.15

175.37

60.09

Provisions and contingencies

Profit After Tax

158

523.69

538.6

172.71

Extraordinary Items

Prior Period Expenses

Other Adjustments

0.00

Net Profit

158

523.69

538.6

172.71

Equity Capital

Face Value (IN RS)

Reserves

Calculated EPS

6.31

20.94

21.54

6.90

Calculated EPS (Annualised)

25.28

83.79

86.17

27.63

No of Public Share Holdings

6250000

% of Public Share Holdings

PBIDTM% (Excl OI)

4.92

16.96

22.75

21.02

PBIDTM%

8.08

19.65

25.50

23.83

PBDTM%

7.88

24.77

25.44

9.66

PBTM%

6.67

23.59

24.16

8.17

PATM%

5.16

16.83

18.22

6.06

Notes

Risk Disclosures on Derivatives

Quarterly Results

ASTRAZENECA PHARMA INDIA LTD.